CURRICULUM VITAE

Dr. Luisa Galli-Stampino
Born in Gallarate (Varese), Italy, on February 13, 1967. Citizenship: Italian.
Address: Immunology
Research Center
Novartis Vaccines Srl
Via Fiorentina 1
53100 Siena, Italy
phone: +39 0577245233/245229
fax: +39 0577539314
e-mail: [email protected]
Education:
1990-1994: “Specializzazione” (Post-Graduate Degree) in Applied Genetics, Universita’
degli Studi di Pavia.
1986-1990: University Degree (Laurea) in Biological Sciences, Universita’ degli Studi di
Pavia.
Honors and Awards:
1992: EU Erasmus Grant, Københavns Universitet, Denmark.
1990: Summa cum Laude Degree (110/110 e lode), Universita’ degli Studi di Pavia.
Membership in Professional Societies:
1992-2013: Registration in the Italian Ordine Nazionale dei Biologi (ONB).
1996-2000: Registration in the European Countries Biologists Association (ECBA).
1
Professional Experience:
2007-present: Research Associate, Novartis Vaccines Srl, Siena, Italy.
1998-2006: Post-Doctoral Fellow, Novartis Vaccines Srl, Siena, Italy.
1999, April-June: Visiting Scientist, Chiron Company, Emeryville, California, U.S.A.
1997, October-December: Associated Research Professor, Institute for Medical
Microbiology and Immunology, Panum Institute, Københavns Universitet, Denmark.
1994, March-1997, June: Post-Doctoral Fellow, M&E Biotech A/S, Copenhagen,
Denmark. Research project, sponsored by the Danish Cancer Society.
1992, May-1994, February: “Specializzazione” Student, “Centro Studi Sclerosi
Multipla”, Universita’ degli Studi di Milano.
1992, January-April: “Specializzazione” Student, Institute for Medical Microbiology and
Immunology, Københavns Universitet, Denmark.
1990, September-1991, September: “Specializzazione” Student, Department of
Genetics and Microbiology “A. Buzzati Traverso”, Universita’ degli Studi di Pavia.
1988, November-1990, June: Pre-Graduate Student, Department of Genetics and
Microbiology “A. Buzzati Traverso”, Universita’ degli Studi di Pavia.
2
Publications:
- Capelli E., Galli Stampino L., Martinetti M., Conte R., Cuccia M. (1991) New class I
HLA histoglobulins: may be markers of cancer transformed cells? Medecin Biologie
Environnement-Bulletin of the European Institute of Ecology and Cancer (INEC) 19(2):
299-304.
- Capelli E., Galli Stampino L. (1992) Nuovi geni HLA di classe I. Il Maggior Sistema di
Istocompatibilità nell'uomo. Collana di monografie di Immunoematologia e Medicina
Trasfusionale, SIITS AICT editore, Roma, 1: 63-67.
- Zaffaroni M., Galli Stampino L., Ghezzi A., Baldini S.M., Zibetti A. (1995) In vitro
cytokine, sCD23 and IgG secretion in multiple sclerosis. J. Neuroimmunol. 61: 1-5.
- Galli-Stampino L., Jensen T., Frische K., Meldal M., Werdelin O., Mouritsen S. (1996)
The role of antigen glycosylation in binding to MHC and in immunogenicity. Peptides in
Immunology, C. H. Schneider editor, Wiley, Chichester, 213-217.
- Frische K., Jensen T., Galli-Stampino L., Mouritsen S., Werdelin O., Meldal M. (1996)
Tumor associated T- and Tn-antigen walks through a silent self T-cell epitope by
multiple column glycopeptide synthesis. Peptides in Immunology, C. H. Schneider
editor, Wiley, Chichester, 219-221.
- Jensen T., Galli-Stampino L., Mouritsen S., Frische K., Peters S., Meldal M.,
Werdelin O. (1996) T cell recognition of Tn-glycosylated peptide antigens. Eur. J.
Immunol. 26: 1342-1349.
- Frische K., Meldal M., Werdelin O., Mouritsen S., Jensen T., Galli-Stampino L., Bock
K. (1996) Multiple column synthesis of a library of T-cell stimulating Tn-antigenic
glycopeptide analogs for the molecular characterization of glycan T-cell specificity. J.
Peptide Sci. 2: 212-222.
- Galli-Stampino L., Meinjohanns E., Frische K., Meldal M., Jensen T., Werdelin O.,
Mouritsen S. (1997) T cell recognition of tumor-associated carbohydrates: the nature of
the glycan moiety plays a decisive role in determining glycopeptide immunogenicity.
Cancer Res. 57: 3214-3222.
- Jensen T., Hansen P., Galli-Stampino L., Mouritsen S., Frische K., Meinjohanns E.,
Meldal M., Werdelin O. (1997) Carbohydrate and peptide specificity of MHC class IIrestricted T cell hybridomas raised against an O-glycosylated self peptide. J. Immunol.
158: 3769-3778.
3
- Meinjohanns E., Meldal M., Jensen T., Werdelin O., Galli-Stampino L., Mouritsen S.,
Bock K. (1997) Versatile solid-phase thiolytic reduction of azido and N-Dts groups in the
synthesis of haemoglobin (67-76) O-glycopeptides and photoaffinity labelled analogues
to study glycan T-cell specificity. J. Chem. Soc. Perkin Trans. 1: 871-884.
- Masciopinto F., Freer G., Burgio V.L., Levy S., Galli-Stampino L., Bendinelli M.,
Houghton M., Abrignani S., Uematsu Y. (2002) Expression of human CD81 in
transgenic mice does not confer susceptibility to hepatitis C virus infection. Virology
304: 187-196.
- Draghi M., Jarman E.R., Grifantini R., Galli-Stampino L., Lamb J.R., Valiante N.M.,
Grandi G. (2002) DNA vaccination in Derp1-allergic mice induces a different profile of
allergen-specific CD8+ effector T cells. Eur. J. Immunol. 32: 3720-3728.
- Galli G., Nuti S., Tavarini S., Galli-Stampino L., De Lalla C., Casorati G., Dellabona
P., Abrignani S. (2003) CD1d-restricted help to B cells by human invariant natural killer
T lymphocytes. J. Exp. Med. 197: 1051-1057.
- Galli G., Nuti S., Tavarini S., Galli-Stampino L., De Lalla C., Casorati G., Dellabona
P., Abrignani S. (2003) Innate immune responses support adaptive immunity: NKT cells
induce B cell activation. Vaccine 21: S2/48-S2/54.
- Galli-Stampino L., Pasqualini A., Pozzato G., Bonino F., Filipponi F., Mosca M.,
Masciopinto F., Abrignani S., Uematsu Y. (2003) Molecular analysis of V HI+ B
lymphocytes in hepatitis C patients. Digest. Liver Dis. 35: 788-794.
- Masciopinto F., Giovani C., Campagnoli S., Galli-Stampino L., Colombatto P.,
Brunetto M., Yen T.S.B., Houghton M., Pileri P., Abrignani S. (2004) Association of
hepatitis C virus envelope proteins with exosomes. Eur. J. Immunol. 34: 2834-2842.
Pursuant to D.lgs 196/03 (Privacy Law), I hereby agree to the handling of my personal
data.
Luisa Galli Stampino
4

Download Report